New Insights at AONN+ Annual Conference on Lung Cancer Screening
As the leading cause of cancer death in the United States, lung cancer remains a critical target for early detection and effective patient navigation. The 16th annual Academy of Oncology Nurse & Patient Navigators (AONN+) Conference featured a pivotal session focused on updated lung cancer screening guidelines and practical strategies to improve adherence among diverse patient populations. The session brought together oncology nurses, navigators, researchers, and clinicians to discuss how updated recommendations can be implemented in real-world cancer care.
Understanding the Updated Guidelines
The latest guidelines emphasize eligibility criteria that aim to identify high-risk individuals who can benefit most from early detection. Attendees reviewed key changes, including refined age ranges, smoking history thresholds, and the role of shared decision making in the screening process. The panel underscored that while criteria may evolve, the overarching goal remains clear: increase access to low-dose CT (LDCT) scans for patients who are most likely to benefit, and reduce mortality through timely detection.
Low-Dose CT as a Cornerstone
Low-dose CT screening is consistently highlighted as the most effective tool for catching lung cancer at a treatable stage. The session explored best practices for coordinating LDCT orders, follow-up, and result communication across multidisciplinary teams. Navigators emphasized the importance of patient education on risks, benefits, and potential false positives to empower informed decisions.
Bridging Gaps in Access and Adherence
One of the central themes was improving adherence to screening recommendations. Barriers such as transportation, financial concerns, health literacy, and mistrust in medical systems can deter eligible patients from completing LDCT screening. The conference stressed targeted outreach, culturally competent education, and community partnerships as ways to expand reach to underserved groups. Navigators shared practical tips for scheduling, reminders, and navigation follow-up to ensure patients return for annual screenings where appropriate.
Shared Decision Making as a Clinical Standard
Shared decision making (SDM) was highlighted as a non-negotiable element of contemporary screening programs. Clinicians and navigators encouraged structured SDM conversations that discuss individual risk, the pros and cons of LDCT, and the patient’s personal values and preferences. Evidence suggests SDM improves patient satisfaction and engagement, which, in turn, supports adherence to screening recommendations.
<h2
